By Tiffany Hu ( May 19, 2021, 4:07 PM EDT) -- Biogen is asking the U.S. Supreme Court to overturn Pfizer's victory challenging a patent for Biogen's blockbuster multiple sclerosis treatment Avonex, saying that the Federal Circuit ignored a key word that wasn't found in prior art....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.